CMPS
COMPASS Pathways
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 0
consensus rating "Strong Buy"
EPS Beats Expectation
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About CMPS
Compass Pathways Plc
A UK developer of psilocybin therapy for the treatment of resistant depression
Pharmaceutical
Invalid Date
09/18/2020
NASDAQ Stock Exchange
166
12-31
Depository Receipts (Ordinary Shares)
33 Broadwick Street, London W1F 0DQ, United Kingdom
--
COMPASS Pathways plc is incorporated in England and Wales. COMPASS Pathways plc is a mental health care company that promotes patient access to evidence-based mental health care innovations. The company is motivated by the need to find better ways to help and empower people with mental health challenges who are not helped by existing therapies, and is pioneering a new psilocybin treatment model that combines psilocybin with psychological support.
Company Financials
EPS
CMPS has released its 2024 Q4 earnings. EPS was reported at -0.63, versus the expected -0.64, beating expectations. The chart below visualizes how CMPS has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available